Magliani W - Search Results

1

Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis.

Polonelli L, Magliani W, Conti S, Bracci L, Lozzi L, Neri P, Adriani D, De Bernardis F, Cassone A. Polonelli L, et al. Among authors: magliani w. Infect Immun. 2003 Nov;71(11):6205-12. doi: 10.1128/IAI.71.11.6205-6212.2003. Infect Immun. 2003. PMID: 14573638 Free PMC article.

2

Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation.

Cenci E, Mencacci A, Spreca A, Montagnoli C, Bacci A, Perruccio K, Velardi A, Magliani W, Conti S, Polonelli L, Romani L. Cenci E, et al. Among authors: magliani w. Infect Immun. 2002 May;70(5):2375-82. doi: 10.1128/IAI.70.5.2375-2382.2002. Infect Immun. 2002. PMID: 11953373 Free PMC article.

3

Therapeutic potential of yeast killer toxin-like antibodies and mimotopes.

Magliani W, Conti S, Salati A, Vaccari S, Ravanetti L, Maffei DL, Polonelli L. Magliani W, et al. FEMS Yeast Res. 2004 Oct;5(1):11-8. doi: 10.1016/j.femsyr.2004.06.010. FEMS Yeast Res. 2004. PMID: 15381118 Review.

4

Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies.

Magliani W, Conti S, Giovati L, Maffei DL, Polonelli L. Magliani W, et al. Front Biosci. 2008 May 1;13:6920-37. doi: 10.2741/3199. Front Biosci. 2008. PMID: 18508705

5

From yeast killer toxins to antibiobodies and beyond.

Magliani W, Conti S, Travassos LR, Polonelli L. Magliani W, et al. FEMS Microbiol Lett. 2008 Nov;288(1):1-8. doi: 10.1111/j.1574-6968.2008.01340.x. FEMS Microbiol Lett. 2008. PMID: 18785931 Review.

6

Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection.

Conti G, Magliani W, Conti S, Nencioni L, Sgarbanti R, Palamara AT, Polonelli L. Conti G, et al. Among authors: magliani w. Antimicrob Agents Chemother. 2008 Dec;52(12):4331-7. doi: 10.1128/AAC.00506-08. Epub 2008 Sep 29. Antimicrob Agents Chemother. 2008. PMID: 18824612 Free PMC article.

7

Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity.

Magliani W, Conti S, de Bernardis F, Gerloni M, Bertolotti D, Mozzoni P, Cassone A, Polonelli L. Magliani W, et al. Nat Biotechnol. 1997 Feb;15(2):155-8. doi: 10.1038/nbt0297-155. Nat Biotechnol. 1997. PMID: 9035141

8

Mycobactericidal activity of human natural, monoclonal, and recombinant yeast killer toxin-like antibodies.

Conti S, Fanti F, Magliani W, Gerloni M, Bertolotti D, Salati A, Cassone A, Polonelli L. Conti S, et al. Among authors: magliani w. J Infect Dis. 1998 Mar;177(3):807-11. doi: 10.1086/517815. J Infect Dis. 1998. PMID: 9498471

9

Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria.

Beninati C, Oggioni MR, Boccanera M, Spinosa MR, Maggi T, Conti S, Magliani W, De Bernardis F, Teti G, Cassone A, Pozzi G, Polonelli L. Beninati C, et al. Among authors: magliani w. Nat Biotechnol. 2000 Oct;18(10):1060-4. doi: 10.1038/80250. Nat Biotechnol. 2000. PMID: 11017043

10

Recombinant Streptococcus gordonii for mucosal delivery of a scFv microbicidal antibody.

Oggioni MR, Beninati C, Boccanera M, Medaglini D, Spinosa MR, Maggi T, Conti S, Magliani W, De Bernardis F, Teti G, Cassone A, Pozzi G, Polonelli L. Oggioni MR, et al. Among authors: magliani w. Int Rev Immunol. 2001;20(2):275-87. doi: 10.3109/08830180109043039. Int Rev Immunol. 2001. PMID: 11878770 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters